Tag Archives: Health

Laboratory

Medical laboratory technicians may function behind the scenes, but the work that they do is exciting, varied and vital to the quality of a patient’s healthcare. Conducting lab tests ordered by doctors and other healthcare providers, these professionals work with human bodily fluids and tissue samples to determine diagnoses and identify abnormalities. They work with microscopes, computers and other automated laboratory machines, where they keep detailed records of the data they compile.

Some medical laboratory technicians prefer the more generalist nature of work at a large hospital lab or independent facility while others pursue a specialty in areas such as immunology, microbiology and clinical chemistry. No matter which approach they choose, they are important members of the healthcare industry whose work is instrumental in determining the correct diagnoses.

Most medical laboratory technicians work in hospitals and medical or diagnostic laboratories; a smaller percentage work in physicians’ and dentists’ offices, or in state or federal agencies. While some of their work involves contact with infectious material or pungent fumes, technicians are always properly protected, wearing goggles, gloves, or masks for much of their workday. They generally keep regular business hours, though some work in the evenings, on nights, weekends, and some holidays, as needed by hospitals and other 24-hour facilities.

Training

Medical lab technicians are trained on the job by a medical laboratory technologist or a senior technician. In some cases, a healthcare or medical professional is the primary trainer. The training duration depends on the employer’s policies and the technician’s previous experience.

Licensing and/or Certification

In some states, medical lab technicians must have a license or be registered to work. Licensure often involves passing an exam or undergoing a certification process, and requirements vary by state.

Along with the mandates of some individual states, many employers require their lab employees to be certified. In these cases, medical lab technicians are certified in general or specialty areas through American Medical Technologists or the

American Society for Clinical Pathology. Technicians keep their certification current by taking advantage of continuing education classes, available through professional associations or employers.

Necessary Skills and Qualities

In addition to their technical skills—such as the ability to understand and operate complex machinery, and to collect and analyze data—medical lab technicians must have an eye for detail. These employees must strive to obtain the most accurate results possible due to the importance of their work. They should possess good manual dexterity for working precisely with microscopic material, and have stamina, too, needed when spending extended time sitting and analyzing a specimen, or when on their feet for long periods during the workday.

Opportunities for Advancement

Medical lab technicians often become medical laboratory technologists—bachelor’s-degree-prepared professionals who perform more complex laboratory work and have a leadership role. Medical lab techs also have a good knowledge base to become scientists, researchers, or even transition into a senior or administrative role. They can also move from allied health to direct patient care jobs, such as nursing; or they can switch fields and work as veterinary, biologic, or chemistry lab technicians.

Nursing

This is an exciting time for nursing, as we position our profession as leaders in improving healthcare for all citizens in our nation. The Affordable Care Act has provisions for advancing the education of nurses, for improving access to healthcare for all and for developing new models of care delivery, many of which provide new roles for registered professional nurses and advanced practice nurses.

I am proud to say that NYULMC Nursing is among the nation’s leaders in shaping the future of nursing. As a Magnet hospital, re-designated in 2009, we embody the forces of magnetism, and are committed to the best practice environment for nurses to deliver the highest quality care to their patients.

Our professional model, the DNA of Nursing, has three components: evidence-based practice, caring and leadership. Our model’s building blocks of practice, collaboration, communication and professional development provide a foundation from which NYULMC nurses demonstrate the highest level of professional nursing practice for our patients and their families.

Here at NYULMC, nurses can choose from many clinical services and programs to begin or mature a professional career path that can span decades. The many opportunities that are available for nurses at all levels from new Baccalaureate RN graduates to Advanced Practice Nurses offer the ability to deliver world class nursing care in an intellectually-stimulating academic environment. Nurses at NYULMC demonstrate their professional practice through participation in the various councils that govern the practice of nursing, the quality of our care, and the discovery of new knowledge.

Continuous learning is a way of life at NYULMC. Nurses address the pursuit of new knowledge through our many educational programs, through participation in our Nursing Research Council, and our McClure Scholars Program, where nationally-known nurse researchers join us for a year and lead us in developing a staff-designed evidenced-based project that improves care to our patients. The Susan Bowar-Ferres Research Scholar Fund supports individual staff nurses in gaining expertise in evidence-based practice and research.

Join us in our journey to serve our patients and their families through excellence in caring, and to discover new knowledge that helps our patients’ live better, longer and more productive lives. Please explore our website and I look forward to the opportunity to meet you and discuss your role in leading high quality and safe patient care at NYULMC.

B.D.S

The idea of writing brief information about majority of countries in this region is to give an idea to readers about diversity among all countries in terms of size of the country, population, blood collection, types of BTS, presence of national blood policy and existing regulations. It is evident that there is no similarity on above parameters on member countries. Even the size of the country does not influence the quality of BTS. Three relatively larger countries i.e. India, Bangladesh and Pakistan have highly fragmented BTS. On the other side, smaller countries like Sri Lanka have set an excellent example of a nationally coordinated effective BTS. If we analyze above data, we can see that voluntary blood donation is high in Sri Lanka (86%) and Thailand (> 95%). On the other hand, Pakistan (~90%) and Timor-Leste (80%) has high dependence of family relative donors. Paid blood donors are discouraged by all international agencies like WHO and International Red Cross Crescent Society (IRCS). However, paid donors exist officially in Pakistan and Bangladesh and about 10% blood is collected from this source. In the region, only 66% blood is collected from voluntary sources and repeat voluntary donors are still less in number. If we look into total yearly requirement, this region needs more than 17 million units and there is a deficit of 6.5 million units every year.

Testing for infectious markers is the basic necessity to make transfusion safe. As per country regulation, types of tests and minimum standard are defined by each country. Every country is supposed to do at least three viral markers like HIV, hepatitis B and C. Thailand is the only country which does NAT testing

regularly on majority of blood units collected to reduce the possibility of viral diseases transmission. However, 20-40% of total blood units are not screened in Pakistan for any disease markers probably due to weak regulatory surveillance system. All other countries do these tests as on record. It is a well-known fact that carrying out tests in BTS is not sufficient unless proper quality system is implemented. Most of the countries need properly managed quality management system assisted by international agencies like WHO or by an intra governmental organization like SAARC or ASAIN. It would have been ideal if an accreditation or a grading program could have been planned for these countries for measuring continuous quality improvement.

Another weak area is the component preparation and rational use of blood. Only 37% blood is separated into component and remaining 63% is transfused as whole blood. Demand for component is limited due to lack of awareness among clinicians and non availability of sufficient components. Both are a vicious cycle. Component preparation may increase economical use of a scarce resource and reduce dependence on blood donors. It needs a commitment for all stake holders like government, blood bankers and clinicians.

Another area which needs improvement is hemovigilance. It is almost nonexistent in this region due to lack of proper coordinating agency at inter and intra country level. Therefore, we do not know long-term implications of blood transfusion on patients in this part of the world. Lack of governance and commitment from governments and regulatory bodies allows BTS to slip down from desired quality standard. Even many blood centers do not follow minimum quality standard for their financial gains, especially in private sectors. A good example is unscreened blood transfusion in Pakistan and continuance of paid donors in Bangladesh and Pakistan. Probably, the only way out is the community mobilization with multipronged approached involving, all stake holders including general public, government, blood bankers, clinicians, NGOs, international agencies like WHO/ IFRC and various funding agencies. It is time to work together.

What is Leukaemia? – A Full Guide At Sundas Foundation

What is Leukaemia?

cancer child

What is Leukaemia

What is Leukaemia is a type of cancer found in your blood and bone marrow and is caused by the rapid production of abnormal white blood cells. These abnormal white blood cells are not able to fight infection and impair the ability of the bone marrow to produce red blood cells and platelets.

What is Leukaemia: Leukaemia can be either acute or chronic. Chronic leukaemia progresses more slowly than acute leukaemia, which requires immediate treatment. Leukaemia is also classified as lymphocytic or myelogenous. Lymphocytic leukaemia refers to abnormal cell growth in the marrow cells that become lymphocytes, a type of white blood cell that plays a role in the immune system. In myelogenous leukaemia, abnormal cell growth occurs in the marrow cells that mature into red blood cells, white blood cells, and platelets. There are four broad classifications of leukaemia:

  • Acute lymphocytic leukaemia (ALL)
  • Acute myelogenous leukaemia (AML)
  • Chronic lymphocytic leukaemia (CLL)
  • Chronic myelogenous leukaemia (CML)

What is Leukaemia: Leukaemia occurs in both adults and children. ALL is the most common form ofchildhood leukaemia, and AML is the second most common. Decades of research have led to vastly improved outcomes for children diagnosed with ALL. The two most common adult leukaemia are AML and CLL.

Am I at Risk?

Although experts are uncertain about the causes of leukaemia, they have identified several risk factors that include the following:

  • Exposure to high levels of radiation
  • Repeated exposure to certain chemicals (for example, benzene)
  • Chemotherapy
  • Down Syndrome
  • A strong family history of leukaemia

Symptoms vary depending on the type and stage of leukaemia, but they can include the following:

  • Fever, chills, night sweats and other flu-like symptoms
  • Weakness and fatigue
  • Swollen or bleeding gums
  • Headaches
  • Enlarged liver and spleen
  • Swollen tonsils
  • Bone pain
  • Paleness
  • Pinhead-size red spots on the skin
  • Weight loss

What is Leukaemia How Is Leukaemia Treated?

Your doctor will conduct a complete blood count (CBC) to determine if you have leukaemia. This test will reveal if you have leukaemic cells, or abnormal levels of white blood cells; both are signs of leukaemia. Abnormally low red blood cell or platelet counts can also indicate leukaemia. If you test positive for leukaemia, your doctor will perform a biopsy of your bone marrow to determine which type you have.

Treatment depends on your age, general health, and type of leukaemia. You might receive a combination of treatments that could include chemotherapy, biological therapy, radiation therapy, and stem cell transplantation. Patients with acute leukaemia often undergo chemotherapy because this type of treatment targets fast-dividing cells. Many acute leukaemia patients have responded successfully to treatment. On the other hand, because the cells divide more slowly in chronic leukaemia, it is better treated with targeted therapies that attack slowly dividing cells as opposed to traditional chemotherapy that targets rapidly dividing cells.

For some patients, participating in a clinical trial provides access to experimental therapies. If you are diagnosed with leukemia, talk with your doctor about whether joining a clinical trial is right for you.

Is Leukaemia Preventable?

Because the cause of leukaemia remains unknown, there is no certain way to prevent it. However, avoiding exposure to solvents, such as benzene and toluene, and unnecessary exposure to x-rays is generally good practice. If you think you may be exhibiting signs of leukaemia, being aware of the risk factors and symptoms and talking with your doctor are critical to early diagnosis and treatment. It is especially important for people who have a family history of leukaemia to be aware of symptoms and share their family medical history with their doctors.

Chronic Myeloid Leukaemia: A Patient’s Journey

Where Can I Find More Information?

If you find that you are interested in learning more about blood diseases and disorders, here are a few other resources that may be of some help:

Results of Clinical Studies Published in Blood

Search Blood, the official journal of ASH, for the results of the latest blood research. While recent articles generally require a subscriber login, patients interested in viewing an access-controlled article in Blood may obtain a copy by e-mailing a request to the Blood Publishing Office.

Patient Groups

A list of Web links to patient groups and other organizations that provide information.

Sundas Foundation

What is Blood Cancer? – A Full Guide At Sundas Foundation

 

 

 

What is Blood Cancer?

What is Blood Cancer?

There are three main groups of blood cancer: leukaemia, lymphoma and myeloma

What is Blood Cancer? Blood cancer is an umbrella term for cancers that affect the blood, bone marrow and lymphatic system.

Unfortunately, blood cancer affects a large number of people. Every 20 minutes, someone in the UK is told they have a blood cancer. That’s 70 people a day, 25,000 people a year.

There are three main groups of blood cancer: leukaemia, lymphoma and myeloma. Some types are more common than others:

  • Non-Hodgkin lymphoma is the sixth most common cancer in the UK
  • Leukaemia is the eleventh most common cancer in the UK
  • Other types of blood cancer – such as myeloma – are less common.

Find out more about types of blood cancer and their treatments:

  • Leukaemia
  • Lymphoma
  • Myeloma
  • Myelodysplastic syndromes (MDS)
  • Treatments for blood cancer

Leukaemia

What is Blood Cancer?

Leukaemia affects your white blood cells. These are an important, infection-fighting part of your immune system, made in your bone marrow.

If you have leukaemia, you produce an abnormal number of immature white blood cells which ‘clog up’ your bone marrow and stop it making other blood cells vital for a balanced immune system and healthy blood.

Acute leukaemia comes on suddenly, progresses quickly and needs to be treated urgently. Chronic leukaemia develops more slowly, over months or years.

There are four main types of leukaemia:

  • Acute myeloid leukaemia (AML). It affects around 2,600 adults a year in the UK.  It’s most common in people over 65, although people of any age can get it.
  • Acute lymphoblastic leukaemia (ALL). This is the most common type of leukaemia in children. ALL affects around 650 people a year in the UK. About half the cases are in adults and half in children.
  • Chronic myeloid leukaemia (CML). It’s also quite a rare condition: only about 700 people every year are affected.
  • Chronic lymphocytic leukaemia (CLL). Doctors diagnose just over 3,200 people with CLL a year in the UK. It’s much more common to get it if you’re over 60 and is very rare in people under 40.

Other types of leukaemia include:

  • acute promyelocytic leukaemia (APL)
  • hairy cell leukaemia (HCL)
  • large granular lymphocytic leukaemia (LGL)
  • t-cell acute lymphoblastic leukaemia (T-ALL)
  • chronic myelomonocytic leukaemia (CMML)

Lymphoma

What is Blood Cancer?

Lymphoma is a type of blood cancer that affects your lymphatic system, an important part of your immune system which helps to protect your body from infection and disease.

If you have lymphoma it means you make too many lymphocytes, a type of white blood cell. Your lymphocytes also live longer than they should. This overload compromises your immune system.

Lymphoma can develop in many parts of your body, including your lymph nodes, bone marrow, blood, spleen and other organs.

The two main types of lymphoma are:

  • Non-Hodgkin lymphoma (NHL). Most lymphomas are NHL – it’s the sixth most common cancer in the UK. Each year, around 12,000 people are diagnosed with it in the UK. It’s more common in older people – 1 in 6 (60%) people diagnosed with NHL are over 65.
  • Hodgkin lymphoma (used to be called Hodgkin disease). This is less common, and makes up less than 1% of all cancers in the UK. Around 1,800 people a year are diagnosed with Hodgkin lymphoma. Hodgkin lymphoma can develop at any age, but it’s most common in young adults and in older men and women.

Myeloma

What is Blood Cancer?

Myeloma (also called multiple myeloma) is a blood cancer of the plasma cells. Plasma cells are found in your bone marrow and produce antibodies which help fight infection.

In myeloma, unusually large numbers of abnormal plasma cells gather in your bone marrow and stop it producing an important part of your immune system.

In the UK, just under 4,800 people are diagnosed with myeloma each year. The risk of myeloma increases as you get older – about 4 out of 10 (40%) of cases are in people aged over 75.

Myelodysplastic syndromes (MDS)

The myelodysplastic syndromes (MDS) are a group of blood disorders where a person’s bone marrow is not producing the correct amount and quality of blood cells. Red, white and platelet cells can be affected.

These problems lead to people with MDS feeling very tired, weak and bleeding or bruising more easily.  There are different levels of severity of MDS, it’s not a type of leukaemia but can sometimes lead to acute myeloid leukaemia. MDS is rare – about 4 in every 100,000 people get MDS.  It mainly affects older people, and is more common in people over 70 years old.

If you have low or intermediate risk MDS you may not need treatment straightaway, but regular blood transfusions and medication can help. Some people with more severe MDS can have chemotherapy and a small number of people may need to have a stem cell transplant

Treatments for blood cancer

When it comes to deciding on the best treatment, it all depends what type of blood cancer you have, how advanced and aggressive it is and your general health. Your doctor will suggest the most effective course of treatment for you.

Common treatments are chemotherapy, radiotherapy and, in some cases, a stem cell or bone marrow transplant.

What is chemotherapy?

What is Blood Cancer

Chemotherapy involves taking drugs that destroy cancer cells, hopefully putting it into remission or significantly slowing down the progression of the disease.

There are many types of chemotherapy drugs and they work in different ways. Sometimes doctors will prescribe a single drug, but often they’ll recommend combining two or more because they often work better together. Chemotherapy can be used on its own, but it’s often combined with other treatments like radiotherapy. Chemotherapy is designed to attack cells that are growing and multiplying. That’s because cancer cells grow and multiply faster than healthy cells.

Some healthy cells can be caught in the crossfire, as they can also be growing and dividing quickly. This can cause side effects such as nausea, tiredness and hair loss.

If you’re getting ready for a stem cell, bone marrow or cord blood transplant, you’ll also need chemotherapy to suppress your immune system and stop it attacking your donor’s new ‘foreign’ cells. This is called conditioning therapy.

What is radiotherapy?

Radiotherapy works by using high-energy X-rays to kill cancer cells.

For it to be effective, doctors need to give just the right amount of radiation, targeted at the right area of the body. That’s why you get radiotherapy in specialist centres where doctors, physicists and radiographers work together. They’ll normally use a machine called a ‘linear accelerator’ for the treatment.

Radiotherapy can treat some types of leukaemia and lymphoma. Doctors can also use it to prepare a patient for a stem cell, bone marrow or cord blood transplant as part of the conditioning therapy. A low dose of radiation will lower someone’s immune system, so they’re less likely to reject donor cells. The type of radiotherapy you might have before a stem cell transplant is called total body irradiation or TBI and this means it affects the whole body.

Radiotherapy can also damage normal cells, which can cause side effects. These vary greatly for each person; some experiencing mild symptoms such as tiredness while for others it can be more debilitating.  These side effects will normally have passed within a few weeks of the treatment finishing.

When radiotherapy finishes, most of your body’s healthy cells will continue to grow normally again. But radiotherapy can have long-term side effects.

 

Sundas Foundation

What is Haemophilia? – A Full Guide At Sundas Foundation

What is HAEMOPHILIA Haemophilia

What is Haemophilia

The word Haemophilia derives from two Greek words: haima, meaning blood, and philia, meaning affection.

Haemophilia is a hereditary condition. This means that it is passed on from mother to child at the time of conception.

The blood of a person with Haemophilia does not clot normally. He does not bleed more profusely or more quickly than other people; however, he bleeds for a longer time.

 

What is Haemophilia: Many people believe that Haemophiliacs bleed a lot from minor cuts. This is a myth. External wounds are usually not serious. Far more important is internal bleeding (haemorrhaging). These haemorrhages are in joints, especially knees, ankles and elbows; and into tissues and muscles. When bleeding occurs in a vital organ, especially the brain, a Haemophiliac’s life is in danger.

What are other names for Haemophilia A?

Haemophilia A is called by two other names:

  • Classical Haemophilia, because it is the most common of the factor deficiencies and
  • Factor VIII deficiency Haemophilia, because it is the lack of the factor 8 (written factor VIII) proteins in the blood that causes the clotting problem.

What are other names for Haemophilia B?

Haemophilia B also goes by two other names:

  • Christmas Disease, named after Steven Christmas, a Canadian who in 1952 was the first person to be diagnosed with this distinct form of Haemophilia and
  • Factor IX deficiency Haemophilia, because factor 9 (written factor IX) is the blood protein which is lacking and whose absence slows down the normal clotting process.

How common is Haemophilia?

What is Haemophilia: Both Haemophilia A and B are very rare disorders. Haemophilia A affects fewer than 1 in 10,000 people, or about 2500 Canadians. Haemophilia B is even less common, affecting approximately 1 in 50,000 people, or about 600 Canadians.

Haemophilia affects people of all races, colours and ethnic origins.

Who is affected by Haemophilia?

The most severe forms of Haemophilia affect almost only males. Females can be seriously affected only if the father is a Haemophiliac and the mother is a carrier, or in the case of X-inactivation when a woman’s normal X-chromosome is inactive in the production of factor VIII or IX. These cases are extremely rare. (See Heredity of Haemophilia.)

However, many women who are carriers have symptoms of mild Haemophilia. We are only now fully recognizing the importance of bleeding in carriers and the degree to which these symptoms affect a woman’s quality of life.

As Haemophilia is an hereditary disorder, people are affected at birth. This means that children can have Haemophilia. In fact, Haemophilia is often diagnosed in the first year of life.

How serious is Haemophilia?

Without proper treatment, Haemophilia is crippling and often fatal. With modern treatment, most people with Haemophilia can lead full, active lives.

Haemophilia is classified as severe, moderate or mild.

CLASSIFICATION

LEVEL OF FACTOR VIII OR IX IN THE BLOOD

Severe Less than 1% of normal
Moderate 1 to 5% of normal
Mild 5 to 30% of normal

Severe Haemophiliacs with less than 1% of the normal level of factor VIII or IX in the blood have haemorrhages several times a month. The bleeding is often the result of a minor bump or twist. Sometimes, there is often no apparent cause for the bleeding.

Moderate Haemophiliacs bleed less often. Their haemorrhages are often the result of minor trauma, such as a sports injury.

Mild Haemophiliacs have even fewer haemorrhages. They may be aware of their bleeding problem only in the case of surgery, a tooth extraction or a serious injury. Women with mild Haemophilia may bleed more during menstruation (Periods).

Sundas Foundation

What is Thalassemia

What is Thalassemia

anaconda

Is just like an anaconda in a swamp, which lies hidden from the sight till it pounces on its prey and then doesn’t let go.

What is Thalassemia?

Thalassemia is a group of inherited blood disorders that affect the body’s ability to produce hemoglobin and red blood cells – patients have a lower-than-normal number of red blood cells in their bodies and too little hemoglobin. In many cases the red blood cells are too small.

Our red blood cells carry hemoglobin. Hemoglobin, a protein, carries the oxygen we breathe in through our lungs and transports it to the rest of the body. A spongy material inside some of our bones – bone marrow – uses iron that our body takes from food and makes hemoglobin.

The bone marrow of people with Thalassemia does not produce enough healthy hemoglobin or red blood cells, which causes anemia and fatigue, because the body is short of oxygen. In more severe Thalassemia cases, the patient’s organs may be damaged, there is restricted growth, heart failure, liver damage, and even death.

People with mild thalassemia may not require any treatment at all. In more severe forms of the disease, the patient may need regular blood transfusions. Doing plenty of exercises and eating a healthy diet can help some of the symptoms of thalassemia, especially fatigue.

New guidelines for NTDT – in July, 2013, the Thalassaemia International Federation (TIF) issued guidelines aimed to provide doctors with simple protocols to improve the management and detection of NTDT (non-transfusion- dependent Thalassaemia). “Guidelines for the Management of Non Transfusion Dependent Thalassaemia (NTDT)”

Sundas Foundation

Two alpha globin and two beta globin protein chains make up hemoglobin. There are two types of thalassemia:

Alpha Thalassemia

The alpha thalassemia patient’s hemoglobin does not produce enough alpha protein. This type is commonly found in southern China, Southeast Asia, India, the Middle East, and Africa.

To make alpha globin protein chains we need four genes, two on each chromosome 16. We get two from each parent. If at least one of these genes is missing, it produces alpha thalassemia. The severity of thalassemia depends on how many genes are faulty.

  • One faulty (mutated) gene – there are either no symptoms at all, or they are very mild. A person who is apparently “healthy” and has a child with symptoms of thalassemia is known as aSilent Carrier. This type is also known as alpha thalassemia minima, or 2 trait.
  • Two mutated genes – the patient will have mild anemia. Also known as alpha thalassemia minor, or 1 trait.
  • Three mutated genes – the patient will have hemoglobin H disease, i.e. chronic anemia. A person with hemoglobin H disease needs regular blood transfusions throughout his/her life.
  • Four genes are mutated – the patient has alpha thalassemia major, the severest form of this type of thalassemia. Fetuses with four mutated genes cannot produce normal hemoglobin and do not survive. Blood transfusions given to the fetus have a low success rate. This type of thalassemia is also known as hemoglobin Bart hydrops fetalis.

Beta Thalassemia

We need two globin genes to make beta globin chains. We get one from each parent. If one or two of these genes are faulty, it produces beta thalassemia.

Severity of beta thalassemia also depends on how many genes are mutated:

  • If one globin gene is mutated – the patient may have Beta thalassemia minor.
  • If both globin genes are mutated – the patient may have either moderate or severe symptoms (Colley’s anemia).

Beta thalassemia ( What is Thalassemia ) is much more common among people of Mediterranean ancestry, hence its other name, Mediterranean anemia. It is also more prevalent in North Africa and West Asia. Sixteen percent of the people in the Maldives, some islands in the Indian Ocean, are carriers.

What are the Signs and Symptoms Of Thalassemia & What is Thalassemia?

Signs And Symptoms Of Beta Thalassemia

The majority of infants with beta thalassemia will not have symptoms until they reach six months, because they start off with a different type of hemoglobin called fetal hemoglobin. After the age of six months “normal” hemoglobin starts replacing the fetal one.

People with Thalassemia mainly have anemia-like symptoms.

  • Jaundice
  • Fatigue
  • Pale skin
  • Cold hands and feet
  • Shortness of breath
  • Poor feeding
  • Delayed growth
  • Skeletal deformities – in some cases as the body tries to produce more bone marrow
  • Too much iron – the body will try to absorb more iron to compensate. Iron may also accumulate from blood transfusions. Excessive iron can harm the spleen,heart and liver
  • Greater susceptibility to infections
  • Delayedpuberty

Signs And Symptoms Of Alpha Thalassemia

The majority of children with hemoglobin H are generally healthy. Symptoms will range from mild to moderate anemia.

  • Fatigue
  • Drowsiness
  • Chest pain
  • Pale skin
  • Cold hands and feet
  • Headaches
  • Dizziness and feeling faint
  • Shortness of breath

If treated properly by a good doctor, and the child with Hemoglobin H follows a healthy diet and is physically active, he/she will not become ill more frequently than other kids. Illnesses may last longer and symptoms may be more severe compared to other children. Some patients may need blood transfusions when they are ill.

Patients with Hemoglobin H have a higher risk of gallstones and an enlarged spleen.

Most fetuses with alpha thalassemia (What is Thalassemia) major die before birth; those that manage to survive until the end of pregnancy are usually stillborn. An ultrasound scan can usually detect hydrops fetalis; the fetus will have excessive accumulation of fluids.

Diagnosing thalassemia & What is Thalassemia?

Most children with moderate to severe thalassemia are diagnosed by the end of their second year. People with no symptoms may not realize until they have a child with thalassemia and are then diagnosed as carriers.

If the doctor suspects thalassemia, certain blood tests may be ordered:

  • A complete blood count (CBC)– to measure hemoglobin levels, quantities of red blood cells and their size. Not only do patients with thalassemia have less hemoglobin than normal, their red blood cells may be particularly small.
  • A reticulocyte count – this blood test measures how fast red blood cells (reticulocytes) are being made by the bone marrow and released into the blood. Reticulocytes are usually in the bloodstream for approximately two days before they develop into mature red blood cells. Between 1% to 2% of a healthy person’s red blood cells are reticulocytes.
  • Iron– studies of iron will help the doctor determine whether the anemia is caused by thalassemia or iron deficiency. For people with thalassemia, iron deficiency is not the cause.
  • Genetic testing– DNA analysis will help either diagnose thalassemia or tell whether a person is carrying faulty hemoglobin genes.

Prenatal testing for thalassemia – to find out whether the fetus has thalassemia and how severe it might be. The following tests may be done:

  • Chorionic villus sampling– a piece of the placenta is taken out and checked in the laboratory. This is usually done at the end of the first trimester, around the 11th week of pregnancy.
  • Amniocentesis– a sample of amniotic fluid is taken. This usually occurs during the 16th week of pregnancy. Amniotic fluid is a clear, slightly yellowish liquid that surrounds the fetus.

What are the treatment options for Thalassemia & What is Thalassemia?

  • Blood transfusions– this is done to replenish hemoglobin and red blood cell levels. Patients with moderate to severe thalassemia will have repeat transfusions every 4 months, while those with more severe disease may require transfusions every two to four weeks. Patients with mild symptoms may require occasional transfusions when they are ill or have an infection.
  • Iron chelation– involves removing excess iron from the bloodstream. Sometimes blood transfusions can cause iron overload. Iron overload is bad for the heart and some other organs. Patients may be prescribed subcutaneous (injected under the skin) deferoxamine or oral (taken by mouth) deferasirox.Folic acid supplements may be prescribed for patients who are administered blood transfusions and chelation.
  • Bone marrow transplant– also called a stem cell  Bone marrow is a spongy tissue that exists in the hollow centers of large bones. Bone marrow cells produce red and white blood cells, hemoglobin and platelets.Doctors say that a bone marrow transplant (from a compatible donor) is the most effective treatment. However, there are significant risks.
  • Surgery– some patients with bone abnormalities may require surgery.

What are the complications of thalassemia?

  • The most common complications include:
  • Iron overload– this may be because of the frequent blood transfusions or the disease itself.Iron overload raises the risk of hepatitis (swollen liver), fibrosis (enlarged liver) and cirrhosis (liver becomes progressively damaged by scarring).The endocrine system includes glands that produce hormones. The pituitary gland is particularly sensitive to iron overload and can become damaged, which may lead to delayed puberty and restricted growth. Later on after puberty the patient may be at a higher risk of developing diabetes, and having either an underactive or overactive thyroid gland.

Iron overload raises the risk of arrhythmias (abnormal heart rhythms) and congestive heart failure.

  • Enlarged spleen (splenomegaly)– also known as hypersplenism. The spleen recycles red blood cells. In patients with thalassemia the red blood cells may have an abnormal shape, making it harder for the spleen to recycle them; the red blood cells accumulate in the spleen, making it grow. An enlarged spleen can become overactive – it starts destroying healthy blood cells the patient receives during transfusions. Sometimes the patient may need a splenectomy (surgical removal of the spleen).
  • Infection– if the patient has had his/her spleen removed, there is a greater risk of infection.
  • Bone deformities– in some cases the bone marrow expands, which deforms the bone around it. The bones of the skull and face may be affected. As the bone marrow expands, the bone around it becomes brittle, increasing the risk of fracture.

What is the life expectancy for someone with thalassemia?

According to the American Academy ( What is Thalassemia ) of Family Physicians, a patient with thalassemia trait has a normal life expectancy. Those with beta thalassemia major, on average live 17 years and generally die before their thirtieth birthday. So What is Thalassemia?

The majority of deaths are caused by the heart complications of iron overload.
Sundas Foundation